ReviewNephron2024

Extended-Release Calcifediol: A Data Journey from Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism.

Domenico Merante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.